Abstract:Purpose: Nerve allografts are highly antigenic and, thus, require the continuous use of immunosuppressive drugs. FK 506 was found to pre-vent rejection successfully. However, clinically neurotoxic complications have been noted in the central and peripheral nervous system although an increased rate of axonal regeneration has also been shown after nerve crush experiments. To investigate whether a possible regeneration pro-moting potency of FK 506 is determined via an influence on Schwann cells, Schwann cells were cultured from the sciatic nerve of the rat. Methods: The effect of 100 μM FK 506 administered daily on these cultures was assessed microscopically over a period of seven days and compared to an untreated control group of cultures. Additionally, the changes in intracellular calcium were recorded using a laser scanning microscope. In vivo regeneration of autologous rat sciatic nerve grafts was assessed clinically, histologically and morphometrically after two and six weeks. The animals received a daily administration of 0.6 mg FK 506/kg body weight, the control received saline. Results: In vitro FK 506 increased the Schwann cell number in culture significantly compared to non treated cultures, while the fibrocyte population was decreased. FK 506 caused a transient increase of intracellular calcium levels in cultured cells. In vivo, a significantly higher axon count was observed in the FK 506 treated grafts after two weeks regeneration compared with controls. Good regeneration was noted in all grafts after six weeks regeneration. Conclusions: The increased axon counts and decreased myelin debris in the FK 506 grafts after two weeks indicate an accelerated Wallerian degeneration and increased axon sprouting into the graft initially. The inhibition of calcineurin activity is not the mediator of the neurotrophic effect. FK 506 promotes axonal regeneration through binding to FKBP-12. The increase of intracellular calcium may induce Schwann cell pro-liferation via calmodulin. The therapeutic relevance for autologous nerve grafting, however, has to be defined in further studies.

FK506 contributes to peripheral nerve regeneration by inhibiting neuroinflammatory responses and promoting neuron survival

Repair of Neurological Function in Response to FK506 Through CaN/NFATc1 Pathway Following Traumatic Brain Injury in Rats

Acceleration of peripheral nerve regeneration following FK506 administration

Stimulation of Schwann cell proliferation and axonal regeneration by FK 506

Effect of FK506 in reducing scar formation by inducing fibroblast apoptosis after sciatic nerve injury in rats

FK506 Attenuates the Inflammation in Rat Spinal Cord Injury by Inhibiting the Activation of NF-κB in Microglia Cells

Protection of FK506 Against Neuronal Apoptosis and Axonal Injury Following Experimental Diffuse Axonal Injury.

Promotion of Nerve Regeneration in Peripheral Nerve by Short-Course FK506 after End-to-side Neurorrhaphy.

Effect Of combining FK506 and neurotrophins on neurite branching and elongation

Changes of Ultrastructure of Regenerative Nerve Fibers in Response to Application of Sustained Releasing Agent FK506

Local FK506 dose‐dependent study using a novel three‐dimensional organotypic assay

[Effect of FK506 on the Cavernous Nerve Regeneration after Injury].

FK1706, a novel non-immunosuppressant neurophilin ligand, ameliorates motor dysfunction following spinal cord injury through its neuroregenerative action.

Nerve Wrap for Local Delivery of FK506/Tacrolimus Accelerates Nerve Regeneration

Impairment of early fracture healing by skeletal muscle trauma is restored by FK506

The Neurotrophic Effects and Mechanism of Action for FK1706 in Neurorrhaphy Rat Models and SH-SY5Y Cells

Strain-Specific Differences In The Effects Of Cyclosporin A And Fk506 On The Survival And Regeneration Of Axotomized Retinal Ganglion Cells In Adult Rats

Evaluation of PRGD/FK506/NGF Conduits for Peripheral Nerve Regeneration in Rats

Establishment of FK506-Enriched PLGA Nanomaterial Neural Conduit Produced by Electrospinning for the Repair of Long-Distance Peripheral Nerve Injury

FK506 promotes liver regeneration by suppressing natural killer cell activity

Neuron and Microglia/macrophage-Derived FGF10 Activate Neuronal FGFR2/PI3K/Akt Signaling and Inhibit Microglia/macrophages TLR4/NF-κB-dependent Neuroinflammation to Improve Functional Recovery after Spinal Cord Injury.